Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease
Author:
Open Access
- 30 September 2018
- journal article
- review article
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 37 (3) , 197-209
Abstract
Mitsuo Kato. Kidney Research and Clinical Practice 2018;37:197-209. https://doi.org/10.23876/j.krcp.2018.37.3.197Keywords
This publication has 175 references indexed in Scilit:
- Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical BindingCell, 2013
- Serum microRNAs levels in primary focal segmental glomerulosclerosisPediatric Nephrology, 2013
- MicroRNA Circuits in Transforming Growth Factor-β Actions and Diabetic NephropathySeminars in Nephrology, 2012
- The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathyKidney International, 2011
- Low‐dose paclitaxel ameliorates fibrosis in the remnant kidney model by down‐regulating miR‐192The Journal of Pathology, 2011
- Dicer regulates the development of nephrogenic and ureteric compartments in the mammalian kidneyKidney International, 2011
- Methyl‐CpG‐binding protein 2 is phosphorylated by homeodomain‐interacting protein kinase 2 and contributes to apoptosisEMBO Reports, 2009
- Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for TreatmentSeminars in Nephrology, 2007
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Initial sequencing and analysis of the human genomeNature, 2001